Ray Dalio's IMCR Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 9,952 shares of Immunocore Holdings plc (IMCR) worth $345,434, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Ray Dalio has initiated a new position in IMCR, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Immunocore Holdings plc (IMCR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Immunocore Holdings plc (IMCR) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +9,952 | New Buy | 9,952 | $34.71 |
Ray Dalio's Immunocore Holdings plc Investment FAQs
Ray Dalio first purchased Immunocore Holdings plc (IMCR) in Q4 2025, acquiring 9,952 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Immunocore Holdings plc (IMCR) for 1 quarters since Q4 2025.
Ray Dalio's largest addition to Immunocore Holdings plc (IMCR) was in Q4 2025, adding 9,952 shares worth $345,434.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 9,952 shares of Immunocore Holdings plc (IMCR), valued at approximately $345,434.
As of the Q4 2025 filing, Immunocore Holdings plc (IMCR) represents approximately 0.00% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Immunocore Holdings plc (IMCR) was 9,952 shares, as reported at the end of Q4 2025.